Cargando…
Glioma SOX2 expression decreased after adjuvant therapy
BACKGROUND: SOX2 is regarded as an important marker in stem cell. The change of SOX2 expression after adjuvant therapy in high grade glioma (HGG) remains unknown so far. Few patients with recurrent glioma have opportunity to undergo operation once again, so the recurrent glioma samples are scarce. T...
Autores principales: | Yu, Wei, Ren, Xiaoqiu, Hu, Chunxiu, Tan, Yinuo, Shui, Yongjie, Chen, Zexin, Zhang, Lili, Peng, Jiaping, Wei, Qichun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849258/ https://www.ncbi.nlm.nih.gov/pubmed/31718604 http://dx.doi.org/10.1186/s12885-019-6292-y |
Ejemplares similares
-
Comparison of Immune Checkpoint Molecules PD-1 and PD-L1 in Paired Primary and Recurrent Glioma: Increasing Trend When Recurrence
por: Yu, Wei, et al.
Publicado: (2022) -
Postoperative recurrent patterns of gallbladder cancer: possible implications for adjuvant therapy
por: Yuan, Zhijun, et al.
Publicado: (2022) -
Pancreatic cancer adjuvant radiotherapy target volume design: based on the postoperative local recurrence spatial location
por: Yu, Wei, et al.
Publicado: (2016) -
Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases
por: Zhao, Juan, et al.
Publicado: (2018) -
Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy
por: Yu, Wei, et al.
Publicado: (2019)